세계의 입자선 치료 시장 : 제품 및 서비스, 용도, 암 유형, 유형, 시스템, 16개 이상 국가의 데이터에 대한 초점 - 분석과 예측(2024-2033년)

Global Particle Therapy Market: Focus on Products and Services, Application, Cancer Type, Type, System, and Over 16 Countries´ Data - Analysis and Forecast, 2024-2033

US $ 2,475 ￦ 3,573,000

PDF and Excel (1-3 User License)

PDF 및 Excel 보고서를 동일 사업장에서 3명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 3,825 ￦ 5,522,000

PDF and Excel (Global License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

입자선 치료는 고에너지의 양자, 중성자 또는 중양이온을 이용하는 외부 빔 방사선 치료의 특수한 형태이며, 암치료에서 견인력을 늘리고 있습니다.

시장 확대의 주요 요인은 암의 이환율 증가, 임상 연구에서 입자선 치료의 채택 증가, 지속적 기술의 진보, 세계의 입자선 치료 센터의 급증 등입니다.

세계의 입자선 치료 시장을 조사했으며, 시장 배경·개요, 시장 성장에 대한 각종 영향요인 분석, 특허 동향, 법규제 환경, 시장 규모의 추이·예측, 각종 구분·지역별 상세 분석, 경쟁 구도, 주요 기업의 분석 등을 정리하여 전해드립니다.

시장 세분화

세분화 1 : 용도별

• 치료
• 연구

세분화 2 : 암 유형별

• 소아암
• 폐암
• 유방암
• 두경부암
• 기타 암

세분화 3 : 유형별

• 양자선 치료
• 중입자선 치료

세분화 4 : 시스템별

• 멀티룸 시스템
• 싱글룸 시스템

세분화 6 : 지역별

• 북미
• 유럽
• 아시아태평양
• 기타 지역

목차

주요 요약

범위·정의

제1장 시장

• 동향 : 현재 및 향후 영향 평가
• 공급망의 개요
  • 밸류체인 분석
  • 마켓 맵
• R&D 리뷰
  • 국가·기업별 특허 출원 동향
• 규제 상황
• 주요 세계 이벤트의 영향 분석, COVID-19
• 시장 역학의 개요
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회

제2장 용도

• 용도 세분화
• 용도의 개요
• 세계의 입자선 치료 시장(용도별)
  • 처리
  • 조사
• 세계의 입자선 치료 시장(암 유형별)
  • 소아암
  • 폐암
  • 유방암
  • 두경부암
  • 기타 암

제3장 제품

• 제품 세분화
• 제품 개요
• 세계의 입자선 치료 시장(제품 및 서비스별)
  • 제품
  • 서비스
• 세계의 입자선 치료 시장(유형별)
  • 양자선 치료
  • 중입자선 치료
• 세계의 입자선 치료 시장(시스템별)
  • 멀티룸 시스템
  • 싱글룸 시스템

제4장 지역

• 지역 개요
• 촉진요인·억제요인
• 북미
• 유럽
• 아시아태평양
• 기타 지역

제5장 시장 : 경쟁 벤치마킹·기업 개요

• 다음 프론티어
• 지역적 평가
  • Advanced Oncotherapy Plc.
  • Biosig Technologies, Inc.
  • Danfysik A/S
  • Elekta
  • Hitachi Ltd.
  • IBA
  • Mevion Medical Systems
  • Panacea Medical Technologies
  • Optivus Proton Therapy, Inc.
  • P-Cure
  • ProTom International
  • Provision Healthcare
  • Siemens Healthcare GmbH(Variant Medical Systems, Inc.)
  • Sumitomo Heavy Industries, Ltd.
  • Toshiba Medical Systems Corp.

제6장 조사 방법

KSA

영문 목차

영문목차

“Global Particle Therapy Market Surges Ahead with Unprecedented Growth.”

Particle therapy, a specialized form of external beam radiotherapy utilizing energetic protons, neutrons, or heavy positive ions, is gaining traction in cancer treatment. Market expansion is primarily propelled by factors such as the increasing incidence of cancer, heightened adoption of particle therapy in clinical research, continual technological advancements, and the proliferation of particle therapy centres worldwide.

The study evaluates the competitive landscape, profiling leading players, and assessing their strategies to gain a competitive edge. Additionally, the report discusses the factors driving market growth, challenges and potential risks are addressed, aiding stakeholders in making informed decisions.

With a blend of quantitative and qualitative analysis, this report serves as a valuable resource for industry participants, investors, and decision-makers seeking to understand the dynamics of the global particle therapy market.

Market Segmentation:

Segmentation 1: by Application

• Treatment
• Research

Segmentation 2: by Cancer Type

• Paediatric Cancer
• Lung Cancer
• Breast Cancer
• Head and Neck Cancer
• Other Cancers

Segmentation 3: by Type

• Proton Therapy
• Heavy-Ion Therapy

Segmentation 4: by System

• Multi-room Systems
• Single-room Systems

Segmentation 6: by Region

• North America
• Europe
• Asia-Pacific
• Rest-of-the-World

Key Questions Answered in this Report:

• 1. What is the present size of the global market for particle therapy?

• 2. Who are the major contributors in the global particle therapy Market?

• 3. Which region is experiencing the most rapid growth in the global particle therapy Market?

• 4. Which geographical area holds the largest portion of the global particle therapy Market?

• 5. What is the projected Compound Annual Growth Rate (CAGR) for the particle therapy market?

• 6. What are the primary factors propelling growth in the particle therapy market?

• 7. Which sector is predicted to spearhead the particle therapy market by 2033?

Table of Contents

Executive Summary

Scope and Definition

1. Markets

• 1.1. Trends: Current and Future Impact Assessment
  • 1.1.1. Sample Text
  • 1.1.2. Trend 1- Technological Advancements
  • 1.1.3. Trend 2
  • 1.1.4. Trend 3
• 1.2. Supply Chain Overview
  • 1.2.1. Value Chain Analysis
  • 1.2.2. Market Map
• 1.3. Research and Development Review
  • 1.3.1. Patent Filing Trend (by Country, Company)
• 1.4. Regulatory Landscape
• 1.5. Impact Analysis for Key Global Events- Covid19
• 1.6. Market Dynamics Overview
  • 1.6.1. Market Drivers
  • 1.6.2. Market Restraints
  • 1.6.3. Market Opportunities

2. Application

• 2.1. Application Segmentation
• 2.2. Application Summary
• 2.3. Global Particle Therapy Market (by Application)
  • 2.3.1. Treatment
  • 2.3.2. Research
• 2.4. Global Particle Therapy Market (by Cancer Type)
  • 2.4.1. Paediatric Cancer
  • 2.4.2. Lung Cancer
  • 2.4.3. Breast Cancer
  • 2.4.4. Head and Neck Cancer
  • 2.4.5. Other Cancers

3. Products

• 3.1. Product Segmentation
• 3.2. Product Summary
• 3.3. Global Particle Therapy Market (by Products and Services)
  • 3.3.1. Products
  • 3.3.2. Services
• 3.4. Global Particle Therapy Market (by Type)
  • 3.4.1. Proton Therapy
  • 3.4.2. Heavy-Ion Therapy
• 3.5. Global Particle Therapy Market (By System)
  • 3.5.1. Multi-room Systems
  • 3.5.2. Single-room Systems

4. Regions

• 4.1. Regional Summary
• 4.2. Drivers and Restraints as you go alone……
• 4.3. North America
  • 4.3.1. Regional Overview
  • 4.3.2. Driving Factors for Market Growth
  • 4.3.3. Factors Challenging the Market
  • 4.3.4. Application
  • 4.3.5. Product
  • 4.3.6. U.S.
  • 4.3.7. U.S. Particle Therapy Market by Application
  • 4.3.8. Canada
  • 4.3.9. Canada Particle Therapy Market by Application
• 4.4. Europe
  • 4.4.1. Regional Overview
  • 4.4.2. Driving Factors for Market Growth
  • 4.4.3. Factors Challenging the Market
  • 4.4.4. Application
  • 4.4.5. Product
  • 4.4.6. France
  • 4.4.7. France Particle Therapy Market by Application
  • 4.4.8. Germany
  • 4.4.9. Germany Particle Therapy Market by Application
  • 4.4.10. U.K.
  • 4.4.11. U.K. Particle Therapy Market by Application
  • 4.4.12. Rest of Europe
  • 4.4.13. Rest of Europe Particle Therapy Market by Application
• 4.5. Asia Pacific
  • 4.5.1. Regional Overview
  • 4.5.2. Driving Factors for Market Growth
  • 4.5.3. Factors Challenging the Market
  • 4.5.4. Application
  • 4.5.5. Product
  • 4.5.6. China
  • 4.5.7. China Particle Therapy Market by Application
  • 4.5.8. India
  • 4.5.9. India Particle Therapy Market by Application
  • 4.5.10. Japan
  • 4.5.11. Japan Particle Therapy Market by Application
  • 4.5.12. Rest-of-Asia-Pacific
  • 4.5.13. Rest-of-Asia-Pacific Particle Therapy Market by Application
• 4.6. Rest-of-the-World
  • 4.6.1. Regional Overview
  • 4.6.2. Driving Factors for Market Growth
  • 4.6.3. Factors Challenging the Market
  • 4.6.4. Application
  • 4.6.5. Product
  • 4.6.6. The Middle East and Africa
  • 4.6.7. The Middle East and Africa Particle Therapy Market by Application
  • 4.6.8. Latin America
  • 4.6.9. Latin America Particle Therapy Market by Application

5. Markets - Competitive Benchmarking & Company Profiles

• 5.1. Next Frontiers
• 5.2. Geographic Assessment
  • 5.2.1. Advanced Oncotherapy Plc.
    • 5.2.1.1. Overview
    • 5.2.1.2. Top Products / Product Portfolio
    • 5.2.1.3. Top Competitors
    • 5.2.1.4. Target Customers
    • 5.2.1.5. Key Personnel
    • 5.2.1.6. Analyst View
    • 5.2.1.7. Market Share
  • 5.2.2. Biosig Technologies, Inc.
    • 5.2.2.1. Overview
    • 5.2.2.2. Top Products / Product Portfolio
    • 5.2.2.3. Top Competitors
    • 5.2.2.4. Target Customers
    • 5.2.2.5. Key Personnel
    • 5.2.2.6. Analyst View
    • 5.2.2.7. Market Share
  • 5.2.3. Danfysik A/S
    • 5.2.3.1. Overview
    • 5.2.3.2. Top Products / Product Portfolio
    • 5.2.3.3. Top Competitors
    • 5.2.3.4. Target Customers
    • 5.2.3.5. Key Personnel
    • 5.2.3.6. Analyst View
    • 5.2.3.7. Market Share
  • 5.2.4. Elekta
    • 5.2.4.1. Overview
    • 5.2.4.2. Top Products / Product Portfolio
    • 5.2.4.3. Top Competitors
    • 5.2.4.4. Target Customers
    • 5.2.4.5. Key Personnel
    • 5.2.4.6. Analyst View
    • 5.2.4.7. Market Share
  • 5.2.5. Hitachi Ltd.
    • 5.2.5.1. Overview
    • 5.2.5.2. Top Products / Product Portfolio
    • 5.2.5.3. Top Competitors
    • 5.2.5.4. Target Customers
    • 5.2.5.5. Key Personnel
    • 5.2.5.6. Analyst View
    • 5.2.5.7. Market Share
  • 5.2.6. IBA
    • 5.2.6.1. Overview
    • 5.2.6.2. Top Products / Product Portfolio
    • 5.2.6.3. Top Competitors
    • 5.2.6.4. Target Customers
    • 5.2.6.5. Key Personnel
    • 5.2.6.6. Analyst View
    • 5.2.6.7. Market Share
  • 5.2.7. Mevion Medical Systems
    • 5.2.7.1. Overview
    • 5.2.7.2. Top Products / Product Portfolio
    • 5.2.7.3. Top Competitors
    • 5.2.7.4. Target Customers
    • 5.2.7.5. Key Personnel
    • 5.2.7.6. Analyst View
    • 5.2.7.7. Market Share
  • 5.2.8. Panacea Medical Technologies
    • 5.2.8.1. Overview
    • 5.2.8.2. Top Products / Product Portfolio
    • 5.2.8.3. Top Competitors
    • 5.2.8.4. Target Customers
    • 5.2.8.5. Key Personnel
    • 5.2.8.6. Analyst View
    • 5.2.8.7. Market Share
  • 5.2.9. Optivus Proton Therapy, Inc.
    • 5.2.9.1. Overview
    • 5.2.9.2. Top Products / Product Portfolio
    • 5.2.9.3. Top Competitors
    • 5.2.9.4. Target Customers
    • 5.2.9.5. Key Personnel
    • 5.2.9.6. Analyst View
    • 5.2.9.7. Market Share
  • 5.2.10. P-Cure
    • 5.2.10.1. Overview
    • 5.2.10.2. Top Products / Product Portfolio
    • 5.2.10.3. Top Competitors
    • 5.2.10.4. Target Customers
    • 5.2.10.5. Key Personnel
    • 5.2.10.6. Analyst View
    • 5.2.10.7. Market Share
  • 5.2.11. ProTom International
    • 5.2.11.1. Overview
    • 5.2.11.2. Top Products / Product Portfolio
    • 5.2.11.3. Top Competitors
    • 5.2.11.4. Target Customers
    • 5.2.11.5. Key Personnel
    • 5.2.11.6. Analyst View
    • 5.2.11.7. Market Share
  • 5.2.12. Provision Healthcare
    • 5.2.12.1. Overview
    • 5.2.12.2. Top Products / Product Portfolio
    • 5.2.12.3. Top Competitors
    • 5.2.12.4. Target Customers
    • 5.2.12.5. Key Personnel
    • 5.2.12.6. Analyst View
    • 5.2.12.7. Market Share
  • 5.2.13. Siemens Healthcare GmbH (Variant Medical Systems, Inc.)
    • 5.2.13.1. Overview
    • 5.2.13.2. Top Products / Product Portfolio
    • 5.2.13.3. Top Competitors
    • 5.2.13.4. Target Customers
    • 5.2.13.5. Key Personnel
    • 5.2.13.6. Analyst View
    • 5.2.13.7. Market Share
  • 5.2.14. Sumitomo Heavy Industries, Ltd.
    • 5.2.14.1. Overview
    • 5.2.14.2. Top Products / Product Portfolio
    • 5.2.14.3. Top Competitors
    • 5.2.14.4. Target Customers
    • 5.2.14.5. Key Personnel
    • 5.2.14.6. Analyst View
    • 5.2.14.7. Market Share
  • 5.2.15. Toshiba Medical Systems Corp.
    • 5.2.15.1. Overview
    • 5.2.15.2. Top Products / Product Portfolio
    • 5.2.15.3. Top Competitors
    • 5.2.15.4. Target Customers
    • 5.2.15.5. Key Personnel
    • 5.2.15.6. Analyst View
    • 5.2.15.7. Market Share

6. Research Methodology

• 6.1. Data Sources
  • 6.1.1. Primary Data Sources
  • 6.1.2. Secondary Data Sources
  • 6.1.3. Data Triangulation
• 6.2. Market Estimation and Forecast

관련자료